rs749370794

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP3BS2

The NM_002578.5(PAK3):​c.546_548delAGA​(p.Glu182del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000775 in 1,199,582 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 33 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★★).

Frequency

Genomes: 𝑓 0.000081 ( 0 hom., 4 hem., cov: 23)
Exomes 𝑓: 0.000077 ( 0 hom. 29 hem. )

Consequence

PAK3
NM_002578.5 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:3

Conservation

PhyloP100: 8.19

Publications

0 publications found
Variant links:
Genes affected
PAK3 (HGNC:8592): (p21 (RAC1) activated kinase 3) The protein encoded by this gene is a serine-threonine kinase and forms an activated complex with GTP-bound RAS-like (P21), CDC2 and RAC1. This protein may be necessary for dendritic development and for the rapid cytoskeletal reorganization in dendritic spines associated with synaptic plasticity. Defects in this gene are the cause of a non-syndromic form of X-linked intellectual disability. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2017]
PAK3 Gene-Disease associations (from GenCC):
  • corpus callosum, agenesis of
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • intellectual disability, X-linked 30
    Inheritance: XL Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • X-linked syndromic intellectual disability
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_002578.5
BS2
High Hemizygotes in GnomAd4 at 4 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PAK3NM_002578.5 linkc.546_548delAGA p.Glu182del disruptive_inframe_deletion Exon 9 of 18 ENST00000372007.10 NP_002569.1 O75914-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PAK3ENST00000372007.10 linkc.546_548delAGA p.Glu182del disruptive_inframe_deletion Exon 9 of 18 1 NM_002578.5 ENSP00000361077.4 O75914-2

Frequencies

GnomAD3 genomes
AF:
0.0000812
AC:
9
AN:
110898
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000764
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000132
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000831
AC:
15
AN:
180542
AF XY:
0.0000749
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000366
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000101
Gnomad OTH exome
AF:
0.000223
GnomAD4 exome
AF:
0.0000772
AC:
84
AN:
1088633
Hom.:
0
AF XY:
0.0000816
AC XY:
29
AN XY:
355447
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
26200
American (AMR)
AF:
0.0000284
AC:
1
AN:
35160
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19298
East Asian (EAS)
AF:
0.0000996
AC:
3
AN:
30123
South Asian (SAS)
AF:
0.000167
AC:
9
AN:
53880
European-Finnish (FIN)
AF:
0.0000247
AC:
1
AN:
40494
Middle Eastern (MID)
AF:
0.000487
AC:
2
AN:
4106
European-Non Finnish (NFE)
AF:
0.0000792
AC:
66
AN:
833592
Other (OTH)
AF:
0.0000437
AC:
2
AN:
45780
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.390
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000811
AC:
9
AN:
110949
Hom.:
0
Cov.:
23
AF XY:
0.000120
AC XY:
4
AN XY:
33265
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30630
American (AMR)
AF:
0.00
AC:
0
AN:
10359
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2635
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3518
South Asian (SAS)
AF:
0.000766
AC:
2
AN:
2611
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5963
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.000132
AC:
7
AN:
52833
Other (OTH)
AF:
0.00
AC:
0
AN:
1498
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000434
Hom.:
0
Bravo
AF:
0.0000453

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Intellectual disability, X-linked 30 Uncertain:2
Dec 03, 2017
Genomic Research Center, Shahid Beheshti University of Medical Sciences
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 22, 2021
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
Oct 09, 2023
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant, c.546_548del, results in the deletion of 1 amino acid(s) of the PAK3 protein (p.Glu182del), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with PAK3-related conditions. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
8.2
Mutation Taster
=77/23
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs749370794; hg19: chrX-110406205; COSMIC: COSV53273856; API